EAM
Exane Asset Management Portfolio holdings
AUM
$256M
This Quarter Return
-4.08%
1 Year Return
+8.08%
3 Year Return
+70.48%
5 Year Return
+81.39%
10 Year Return
–
AUM
$192M
AUM Growth
+$192M
(+16%)
Cap. Flow
+$26.2M
Cap. Flow
% of AUM
13.63%
Top 10 Holdings %
Top 10 Hldgs %
78.45%
Holding
36
New
13
Increased
8
Reduced
4
Closed
11
Top Buys
| 1 |
SHPG
Shire pic
SHPG
|
$12.9M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
$12M |
| 3 |
GRA
W.R. Grace & Co.
GRA
|
$8.9M |
| 4 |
MON
Monsanto Co
MON
|
$8.56M |
| 5 |
Westlake Corp
WLK
|
$7.45M |
Top Sells
| 1 |
Deutsche Bank
DB
|
$18.2M |
| 2 |
Gilead Sciences
GILD
|
$7.41M |
| 3 |
Morgan Stanley
MS
|
$7.36M |
| 4 |
CF Industries
CF
|
$7.14M |
| 5 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
$6.82M |
Sector Composition
| 1 | Communication Services | 34.07% |
| 2 | Healthcare | 24.77% |
| 3 | Materials | 12.66% |
| 4 | Financials | 8.78% |
| 5 | Consumer Discretionary | 7.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
T-Mobile US
TMUS
$284B
| $44.1M | 22.98% |
1,152,500
+166,403
| +17% | +$6.37M |
|
2
TIM SA
TIMB
$10.2B
| $21M | 10.91% |
1,894,706
-481,564
| -20% | -$5.33M |
|
|
SHPG
3
DELISTED
Shire pic
SHPG
| $12.9M | 6.69% |
+74,756
| New | +$12.9M |
|
|
AGN
4
DELISTED
Allergan plc
AGN
| $12.3M | 6.41% |
45,923
+18,797
| +69% | +$5.04M |
|
|
5
BioMarin Pharmaceuticals
BMRN
$11.2B
| $12M | 6.26% |
+145,820
| New | +$12M |
|
|
CNH
6
CNH Industrial
CNH
$14.3B
| $11M | 5.71% |
1,612,349
+986,925
| +158% | +$6.71M |
|
|
CELG
7
DELISTED
Celgene Corp
CELG
| $10.3M | 5.39% |
103,368
+28,676
| +38% | +$2.87M |
|
8
Citigroup
C
$178B
| $9.64M | 5.02% |
230,848
+17,366
| +8% | +$725K |
|
|
GRA
9
DELISTED
W.R. Grace & Co.
GRA
| $8.9M | 4.63% |
+125,043
| New | +$8.9M |
|
|
MON
10
DELISTED
Monsanto Co
MON
| $8.56M | 4.46% |
+97,591
| New | +$8.56M |
|
|
11
Westlake Corp
WLK
$11.3B
| $7.45M | 3.88% |
+160,860
| New | +$7.45M |
|
12
Goldman Sachs
GS
$226B
| $7.24M | 3.77% |
+46,097
| New | +$7.24M |
|
13
Sherwin-Williams
SHW
$91.2B
| $6.67M | 3.47% |
23,419
-2,448
| -9% | -$697K |
|
|
GCP
14
DELISTED
GCP Applied Technologies Inc.
GCP
| $5.09M | 2.65% |
+255,459
| New | +$5.09M |
|
15
Aptiv
APTV
$17.3B
| $4.58M | 2.38% |
+60,984
| New | +$4.58M |
|
|
HES
16
DELISTED
Hess
HES
| $2.53M | 1.32% |
48,029
+40,039
| +501% | +$2.11M |
|
17
Schlumberger
SLB
$55B
| $2.11M | 1.1% |
+28,569
| New | +$2.11M |
|
18
Chevron
CVX
$324B
| $1.68M | 0.87% |
17,574
+8,299
| +89% | +$792K |
|
19
Vulcan Materials
VMC
$38.5B
| $1.64M | 0.85% |
15,500
-39,134
| -72% | -$4.13M |
|
|
JOY
20
DELISTED
Joy Global Inc
JOY
| $1.13M | 0.59% |
+70,500
| New | +$1.13M |
|
21
Occidental Petroleum
OXY
$46.9B
| $893K | 0.47% |
13,052
+5,012
| +62% | +$343K |
|
22
Telefônica Brasil
VIV
$20.1B
| $344K | 0.18% |
+27,510
| New | +$344K |
|
23
Biogen
BIIB
$19.4B
| $19K | 0.01% |
+73
| New | +$19K |
|
|
24
Gilead Sciences
GILD
$140B
| $15.9K | 0.01% |
173
-80,623
| -100% | -$7.41M |
|
25
Regeneron Pharmaceuticals
REGN
$61.5B
| $14.4K | 0.01% |
+40
| New | +$14.4K |
|